Incannex Healthcare Ltd (IXHL) Quote

Approx. $2.5M in the 1st Hr. 😀

IXHL looks like the stock has been loaded.....we will see what happens with this stock in July

$IXHL wouldn’t surprised me this goes to $5s very soon - sleep apnea has no FDA approved drug yet. $IXHL drug works huge could be the 1st FDA approved drug multi billion dollar market potential!! #wallstrerbets $NCNA $CARM $MRIN $KLTO https://t.co/VcXHF8n7rV— TheLion Stock Trader (@TheLioncom) June 10, 2025
🔥🔥🔥🔥🔥🔥🔥

$IXHL we’re just gonna sit here and act like this isn’t hitting $3 in like a month or so right?… people will regret not buying here at these levels pic.twitter.com/eG0zijB7kJ— Livi (@BioNerd77) June 12, 2025

🔥🔥🔥🔥🔥🔥

Came in higher yesterday, but added now @ .219 😜

Bought some more!

$IXHL 💹

I see the chart has history of sharp spikes on NEWS - and this upcoming NEWS could be the biggest of all so far. Phase 2 results in July...

Something is running in the background at IXHL from 0.20 - 0.24 uses have been collected for days and I suspect in July (August at the latest) something will happen at IXHL and we will have a strong increase ...... WHEN I SAW THE INCREASE I ALSO GET IN YESTERDAY and now I will wait patiently , imho
here : $IXHL we’re just gonna sit here and act like this isn’t hitting $3 in like a month or so right?… people will regret not buying here at these levels pic.twitter.com/eG0zijB7kJ— Livi (@BioNerd77) June 12, 2025

Good news is expected in July and investors are positioning themselves for a big rise deep into the dollar area....here:
$IXHL wouldn’t surprised me this goes to $5s very soon - sleep apnea has no FDA approved drug yet. $IXHL drug works huge could be the 1st FDA approved drug multi billion dollar market potential!! #wallstrerbets $NCNA $CARM $MRIN $KLTO https://t.co/VcXHF8n7rV— TheLion Stock Trader (@TheLioncom) June 10, 2025

imho

Hey brother - what's going on over here?

IXHL looks like the stock has been loaded.....we will see what happens with this stock in July

$IXHL wouldn’t surprised me this goes to $5s very soon - sleep apnea has no FDA approved drug yet. $IXHL drug works huge could be the 1st FDA approved drug multi billion dollar market potential!! #wallstrerbets $NCNA $CARM $MRIN $KLTO https://t.co/VcXHF8n7rV— TheLion Stock Trader (@TheLioncom) June 10, 2025
🔥🔥🔥🔥🔥🔥🔥

$IXHL we’re just gonna sit here and act like this isn’t hitting $3 in like a month or so right?… people will regret not buying here at these levels pic.twitter.com/eG0zijB7kJ— Livi (@BioNerd77) June 12, 2025

🔥🔥🔥🔥🔥🔥

Looks great

Bought into this one yesterday @ 2.234

$IXHL we’re just gonna sit here and act like this isn’t hitting $3 in like a month or so right?… people will regret not buying here at these levels pic.twitter.com/eG0zijB7kJ— Livi (@BioNerd77) June 12, 2025
🔥🔥🔥🔥🔥🔥

$IXHL wouldn’t surprised me this goes to $5s very soon - sleep apnea has no FDA approved drug yet. $IXHL drug works huge could be the 1st FDA approved drug multi billion dollar market potential!! #wallstrerbets $NCNA $CARM $MRIN $KLTO https://t.co/VcXHF8n7rV— TheLion Stock Trader (@TheLioncom) June 10, 2025
🔥🔥🔥🔥🔥🔥🔥

Look at that volume! Maybe we get the phase 2 results THIS week?? Exciting to be a part of it!

Good morning IXHL-ers!

====================

Nice recent news:

Capital structure streamlined and potential dilution from Series A Warrants eliminated ahead of key Phase 2 clinical milestones

NEW YORK and MELBOURNE, Australia, June 12, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces it has successfully canceled all remaining Series A Warrants pursuant to its letter agreements with the holders of the Series A Warrants, having raised the full amount of capital required to complete the cancellation through its At-The-Market (“ATM”) facility.

This follows the Company’s May 28, 2025, announcement of binding agreements to cancel the final 172 million Series A Warrants in exchange for $12.2 million. Combined with a tranche canceled earlier in May, the initiative removes 347.2 million shares from potential future dilution, fully eliminating the Series A Warrant overhang.

Incannex CEO Joel Latham commented, “Following increased market liquidity, we specifically utilized our ATM facility to fund the cancellation of all outstanding Series A Warrants. This eliminates a significant source of dilution and leaves Incannex with a clean capital structure ahead of key milestones, including the upcoming topline data readout from our Phase 2 RePOSA trial of IHL-42X for obstructive sleep apnea, expected in July 2025. This action reflects our commitment to disciplined capital management and long-term value creation for shareholders.”

IHL-42X is being developed as a potential first-in-class oral therapy for obstructive sleep apnea, a condition affecting millions globally with no FDA-approved drug treatment currently available.

For additional details, refer to the Company’s Form 8-K filed with the SEC on May 28, 2025.

About IHL-42XIHL-42X is designed to treat obstructive sleep apnea (“OSA”) by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase 2/3 clinical trial, which is expected to enroll more than 560 patients at sites worldwide.

Designed to act synergistically, IHL-42X uniquely targets two physiological pathways associated with the intermittent hypoxia (“IH”) and hypercapnia that characterize OSA. In a prior Australian Phase 2 clinical trial, IHL-42X was shown to reduce the Apnea-Hypopnea Index (“AHI”) in all dosage strengths, with the lowest dose reducing AHI by an average of 51 percent relative to baseline. RePOSA, a global Phase 2/3 clinical trial is underway, evaluating IHL-42X in individuals with OSA who are either non-compliant, intolerant, or naïve to positive airway pressure devices, including CPAP, with the Phase 2 portion conducted in the United States. A topline readout from the U.S. Phase 2 portion is anticipated in July 2025.

Unlike weight loss therapies, IHL-42X is uniquely engineered to target two key physiological pathways, intermittent hypoxia (IH) and hypercapnia, that underlie the pathology of OSA. By targeting these core mechanisms, IHL-42X offers a differentiated approach that may benefit a wider range of patients, including the 67% of individuals with OSA who are not classified as obese. OSA affects an estimated 1 billion people globally and approximately 30 million people in the United States. Despite its high prevalence OSA remains significantly underdiagnosed and undertreated. IHL-42X has the potential to address this critical gap in care and improve outcomes for millions living with this serious, chronic condition.

About Incannex Healthcare Inc.Incannex is leading the way in developing combination medicines that target the underlying biological pathways associated with chronic conditions, including obstructive sleep apnea, rheumatoid arthritis and generalized anxiety disorder. The company is advancing three clinical-stage product candidates based on evidence-based innovation, and supported by streamlined operations. Incannex's lead clinical program, IHL-42X, is an oral fixed-dose combination of dronabinol and acetazolamide designed to target underlying mechanisms and act synergistically in the treatment of obstructive sleep apnea. In a Phase 2 development program, IHL-675A is an oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate designed to act synergistically to alleviate inflammatory conditions, such as rheumatoid arthritis. Approved for Phase 2 clinical development, PSX-001 is an oral synthetic psilocybin treatment for the treatment of generalized anxiety disorder. Incannex's programs target disorders that have limited, inadequate, or no approved pharmaceutical treatment options. For additional information on Incannex, please visit our website at www.incannex.com.

====================

From website:

Incannex has pioneered the clinical development of cannabinoid combination products including IHL-42X for OSA and IHL-675A for inflammation. Incannex is the only company developing an oral, synthetic psilocybin (PSX-001) treatment for generalized anxiety disorder administered in combination with psychological support.

https://incannex.com/pipeline-combination-therapies/

$IXHL

We're waiting for a PR sometime in July giving us an update on the results of the Phase 2 trial. If it's positive, then this could jump.

What’s going on with this stock? It hasn’t moved in several weeks now.

$IXHL getting a lot of heat on Stocktwits, could be a great week

New PR today with a new appointment to the advisory board. Looks good!

IXHL - IXHL: Incannex achieves milestone with database lock for RePOSE Phase 2 trial
BUT
Phase 3 and the results are expected in July and if these are positive and successful = we are entering a billion dollar market and the stock can get several dollars, imo

If you read this 8k it is further down = in July garden news is expected to come to the phase (the few days of waiting impatience should be worth it) https://ih.advfn.com/stock-market/NASDAQ/incannex-healthcare-IXHL/stock-news/96229538/form-8-k-current-report
imho

Look at the volume! Keep it coming!

good news now https://ih.advfn.com/stock-market/NASDAQ/incannex-healthcare-IXHL/stock-news/96229520/incannex-healthcare-cancels-all-outstanding-series
😍😍😍

$IXHL SOUNDS LIKE THE NEXT GREAT LONG RUNNER
imho

$IXHL wouldn’t surprised me this goes to $5s very soon - sleep apnea has no FDA approved drug yet. $IXHL drug works huge could be the 1st FDA approved drug multi billion dollar market potential!! #wallstrerbets $NCNA $CARM $MRIN $KLTO https://t.co/VcXHF8n7rV— TheLion Stock Trader (@TheLioncom) June 10, 2025 🔥🔥🔥

IXHL....................................................................................................p/m

Would not be surprised if news drops tomorrow morning.
This volume with a rising share price normally leads to something positive.
Looks like the Company is done selling so maybe this is the start to the upward move towards $ 0.35 to $0.50

We're seeing a lot of volume this morning with a rising PPS! I wonder what's up?

Thanks for the insight and info

$IXHL Plus or minus a few from my back of the napkin math...

Assuming IXHL was only looking to raise enough right now to kill the remaining warrants. $12.2M shares at roughly .20 would = 61M shares needed to sell.

Total volume 28th = 54.5M
29th = 56.43M
30th = 28.71M
Total Vol for the 3 days = 139.64M

If the co selling volume accounted for a bit under 50% of the total volume for the 3 days...then it appears that Friday ah dump to .13 could have completed the raise for the warrants.

I would have to imagine at this price level to keep dilution minimal the company would be looking to raise enough now to kill the warrants...plus maybe a few Mill more and then use the Phase 2 topline results in July to finish the raise at higher prices. I think we might see a PR on the Warrants being evaporated either Monday or Tuesday this week. It would be nice to see this one return back to the .30 - .50 level while we wait for the Ph2 results in July.

Hopefully we either somehow get the jump on drug AD109 for full approval even though they are ahead of us in the process...or we show better results overall. If so things could get really wild here.
This market is huge so I feel like there is room for 2 outside of ZepBound from Lilly. I guess time will tell but our hat is in the ring to remedy on a multi-billion $ global issue.

Hard not to be excited for this one.

imho
mj

Don't  quote me but, the warrants were cancelled so the shareholders would not get diluted down to the warrant pps. Instead the company cancelled the warrants then are diluting themselves to pay the warrants hence the .20 average now. Should be done soon or maybe done already. We will see , either way holding in to July, take these cheap shares as a gift. If mid June we are in the mid 50s... you know what's coming in July.

we are in PHASE 3 awsome

Can someone please explain why eliminating warrants makes our PPS go down? Doesn't this mean that the company buys back these warrants, or are they selling them, which would be the same thing as delution, which the PR says it eliminates. I'm confused.

IXHL news https://finance.yahoo.com/news/incannex-healthcare-inc-enters-agreement-110000307.html

I loaded heavy the last 2 days from .1955 to .205. Holding a full basket for me. I figure at this point the money has been raised and the dilution is now factored in. The vote comes on the 27th to approve the warrant pay off...That will probably then be viewed as a positive event. Looking for a little price increase maybe starting tomorrow? The potential of this product is too much to ignore. It appears there is a private company also going thru clinicals but to this point it looks like we are at least competitive in the space and its a huge market out there.

I'm in

Best of luck to all,

imho
mj

Gap up coming volume still red hot

I'm glad I averaged down an hour ago! Go baby GO!

Million shares a minute

Coming back fast

This should definitely rebound but a lot of bagholders suffering around the low .20's

The challenge is knowing WHEN to pounce! I have some left over powder as well but have no idea when this ticker will make a move upwards again. I feel sorry for all the people that bought this at its peak of over a dollar. Do you think it will come close to a dollar again soon?

have a lot of powder -waiting to pounce

IXHL..............................................................https://stockcharts.com/h-sc/ui?s=IXHL&p=W&b=5&g=0&id=p86431144783

.21 warrants ...assuming full adjustment of the exercise price of the Series A Warrant to the floor price of  per share and exercise pursuant to the zero exercise price provisions of the Series A Warrants)...

I loaded the boat something fierce today...I am prob in your situation as well...but now I've increased my holdings substantially...chipped away all day today from .1950 to .20. Never thought I'd have this many shares of this one. Almost hard to believe that something with this kind of global potential, this late in the game is trading at a cap this low. Lemme see .50 soon pls...thx.

imho
mj

If "Buy the dip" is a good logic to follow...... then this certainly gives us a great dip opportunity! unfortunately I didn't take advantage of a 40% gain and held onto it. So I got some more this morning at the biggest f'ing dip I've ever been a part of.

8k filing warrents
very fortunate to have sold earlier today,
snup

???? wtf